Amber Therapeutics Limited

#02826839 • Active

Amber Therapeutics is pioneering adaptive neuromodulation therapies to treat mixed urinary incontinence in women. Their innovative Picostim™ System targets the pudendal nerve, offering personalized treatment that adapts to individual physiological responses.

Founded: 14 Jun 1993
Industries:
72110 - Research and experimental development on biotechnology
Website: amber-tx.com
Location: Didcot

Products & Services

• adaptive neuromodulation therapy
• adaptive therapy
• biotechnology
• medical device
• neuromodulation
• picostim™ system
• therapeutics
• urinary incontinence

Financial Snapshot

Last accounts made up to 31 Dec 2024
Next accounts due 30 Sept 2026 (8 months)
Cash in Bank
£0.34m
↓ 23%
Turnover
£2.1m
↑ 15%
EBITDA
£0.45m
↑ 8%
Gross Profit
£0.89m
↑ 12%
Total Liabilities
£0.72m
↓ 17%
Employees
14
↑ 0%
Unlock financial data with Pro Start Free Trial →
See Full Financials →

People

Officers
1
Shareholders
2
Controllers (PSC)
2
Aidan Harold Winston Crawley
Director • British • Lives in England • Born in Oct 1983
See Key People →

Registered Office Address

Unit 1 Tech Foundry 2

Curie Avenue

Didcot

OX11 0QQ

England

Basic Information

LTD
14 Jun 1993
ENGLAND WALES
Yes

Industry Classification

72110

Company Attributes

N/A
N/A
N/A
N/A

Summary

13
Officers
2
PSCs
0
Filings